Pfizer advances biosimilars leadership with investment in China
Pfizer announced that it will invest approximately USD$350 million in the development of a state-of-the-art Global Biotechnology Center in China. This innovative facility will be Pfizer’s third biotechnology center globally and the first in Asia. June 28, 2016